Korea Zinc's Acquisition of Igneo Holdings Sparks Controversy Over 100x Seller Profits
7.1.2025 12:09:00 CET | Business Wire | Press Release
The largest shareholder alliance of Korea Zinc - MBK Partners and Young Poong - has called on Chairman Choi Yoon-beom to clarify his connections with the sellers of Igneo Holdings, who reportedly gained profits exceeding 100 times their initial investment during the 2022 acquisition.
A representative from MBK Partners said, “Korea Zinc’s acquisition of Igneo Holdings in 2022 was executed at a valuation that defies market norms, granting the sellers extraordinary profits. The absence of thorough due diligence raises significant questions about the rationale for this transaction. Chairman Choi must provide shareholders with a clear explanation of his relationship with the sellers.”
In 2022, Korea Zinc acquired 100% of Igneo Holdings’ shares in two phases - July and November - via Pedal Point, a subsidiary established earlier that year. The total acquisition cost exceeded KRW 580 billion (approximately USD 450 million at the time). Based on disclosures, Korea Zinc paid a staggering 50 times Igneo’s 2021 revenue for the acquisition, despite Igneo reporting negative equity of KRW -1.9 billion at the end of 2021.
Igneo was founded as recently as February 2021, making it less than 18 months old at the time of the first acquisition in July 2022. Remarkably, negotiations for the acquisition began just five months after Igneo's establishment, in July 2021, with a non-disclosure agreement. The agreed acquisition price - over 100 times the company’s initial capital - was highly unusual for an M&A deal.
Igneo's initial capital was approximately $2.75 million (at $27.50 per share). Korea Zinc, however, paid about $300 million for the acquisition of Igneo's existing shares (at per-share prices of $2,466 in July, $2,621 in November, and $2,708.7 for additional shares), far exceeding 100 times the initial capital. For Igneo's founding shareholders, this translated into a return of 100x on their investment within just 18 months.
The primary sellers included MCC NFT, Igneo’s largest shareholder with a 47.5% stake, alongside investment funds such as PCT Igneo Investor LLC (38.2%), Windchime Limited (5%), and The Tarsadia Group LLC (5.7%). For example, PCT Igneo Investor LLC, which invested only USD 1.05 million, realized over USD 101 million—more than a 100x return within 18 months.
MBK Partners and Young Poong have also highlighted concerns about the relationships between MCC NFT, Tarsadia Group, and other investment funds involved. MCC NFT’s largest shareholder is reportedly The Tarsadia Group, a U.S.-based entity that began in the hotel industry and later pivoted to investments. Many of the funds investing in Igneo, including PCT Igneo Investor LLC, are managed by individuals affiliated with Tarsadia. Tarsadia itself held a direct 5% stake in Igneo and participated in the acquisition of Igneo's convertible bonds (CBs) three months after its founding. These bonds delivered over 11x returns within just 14 months.
“Chairman Choi Yoon-beom has denied knowledge of the relationships among the sellers,” said an MBK Partners representative. “However, such a significant transaction involving hundreds of billions of won cannot proceed without verifying the identities and affiliations of all parties involved. The relationships between MCC NFT, Tarsadia, and the funds they operate, along with the identities of the investors behind these funds, must be disclosed to ensure transparency and protect shareholder interests.”
This controversy has raised broader concerns about corporate governance and accountability in Korea Zinc’s decision-making processes, particularly regarding high-stakes acquisitions.
# # #
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107568189/en/
Contacts
Media Contact
Seikyu Hong,sk.hong@mbkpartnerslp.com
+82 2 3706-8619, +82 10-8944-7798
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom